Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 22
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
30 and over
PVSG-10
Last Modified:
7/1/1991
2.
Phase I/II Study of FLAP (5-FU/LV/AZT/DP) in Patients with Metastatic Colorectal Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
NCI
BRMP-8916C
NCI-90-C-45C, NCI-T89-0135N, T89-0135
Last Modified:
8/1/1991
3.
Phase I/II Study of 14-Day Continuous Infusions of 5-FU/CF with Oral DP in Patients with Advanced Gastrointestinal and Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
20 to 80
TCC-5290
NCI-V91-0020
Last Modified:
5/2/2007
 
First Published:
7/1/1997
4.
Phase II Study of Fluorouracil, Leucovorin, Mitomycin and Dipyridamole in Patients with Locally Advanced Unresected Pancreatic Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
Not specified
NCI
SWOG-S9700
NCT00003018, S9700
5.
Phase II Chemotherapy with MTX/DP in the Treatment of Patients with Metastatic, Locally Recurrent, or Unresectable Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NYU-8505
NCI-V86-0002
6.
Phase II Chemotherapy with DP/MTX/HU/ARA-C in Patients with Advanced Hodgkin's Disease or non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
MRH-860207
UCCRC-4586, NCI-V86-0102
7.
Phase II Study of Chemotherapy with PALA plus Dipyridamole (Persantine) in Patients with Advanced Soft Tissue Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
MSKCC-876
NCI-T86-0200D, T86-0200
Last Modified:
10/1/1988
8.
Phase II Chemotherapy with PALA plus Oral Dipyridamole in Patients with Metastatic non-Small Cell Lung Cancer (Summary Last Modified 10/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
PURDUE-T87-0046
NCI-T87-0046D, T87-0046
Last Modified:
2/1/1989
9.
Phase II Chemotherapy with 5-FU with Biochemical Modulation with Folinic Acid and Dipyridamole in Patients with Advanced Prostate Cancer (Summary Last Modified 02/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
CHNMC-IRB-7082
NCI-V88-0541
Last Modified:
4/26/2007
10.
Phase II Study of VBL/Dipyridamole in Patients with Locally Unresectable or Metastatic Renal Cell Adenocarcinoma (Summary Last Modified 12/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
HOG-GU88-1
NCI-V89-0242
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute